1. Peptidolipins B-F, antibacterial lipopeptides from an ascidian-derived Nocardia sp
- Author
-
Yanpeng Hou, Tim S. Bugni, Doug R. Braun, E Vazquez-Rivera, and Thomas P. Wyche
- Subjects
Methicillin-Resistant Staphylococcus aureus ,Pharmaceutical Science ,Peptidolipin E ,Marine Biology ,Microbial Sensitivity Tests ,Biology ,medicine.disease_cause ,Nocardia ,Article ,Analytical Chemistry ,Microbiology ,Lipopeptides ,Drug Discovery ,medicine ,Animals ,Urochordata ,Pharmacology ,chemistry.chemical_classification ,Molecular Structure ,Organic Chemistry ,Nocardia sp ,biology.organism_classification ,bacterial infections and mycoses ,Trididemnum ,Methicillin-resistant Staphylococcus aureus ,Amino acid ,Anti-Bacterial Agents ,Complementary and alternative medicine ,chemistry ,Staphylococcus aureus ,Molecular Medicine ,Antibacterial activity - Abstract
A marine Nocardia sp. isolated from the ascidian Trididemnum orbiculatum was found to produce five new lipopeptides, peptidolipins B-F (1–5), which show distinct similarities to the previously reported L-Val(6) analog of peptidolipin NA. Synthetic modification of peptidolipin E (4) was used to determine the location of an olefin within the lipid chain. Advanced Marfey’s method was used to determine the absolute configurations of the amino acids. Peptidolipins B (1) and E (4) demonstrated moderate antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA).
- Published
- 2012